Eastwood Bio-Medical Canada Inc.
TSXV:EBM.V
0.51 (CAD) • At close March 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) CAD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.702 | 0.868 | 1.3 | 0.981 | 0.718 | 1.293 | 0.744 | 0.48 | 0.464 | 1.186 | 0.462 | 0.58 |
| Cost of Revenue
| 0.248 | 0.427 | 0.397 | 0.523 | 0.505 | 0.728 | 0.361 | 0.274 | 0.263 | 0.817 | 0.217 | 0.172 |
| Gross Profit
| 0.454 | 0.441 | 0.903 | 0.458 | 0.213 | 0.565 | 0.383 | 0.205 | 0.2 | 0.37 | 0.244 | 0.408 |
| Gross Profit Ratio
| 0.647 | 0.508 | 0.695 | 0.467 | 0.297 | 0.437 | 0.514 | 0.428 | 0.432 | 0.312 | 0.529 | 0.704 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0.524 | 0.667 | 0.923 | 0.952 | 1.058 | 1.067 | 0.746 | 0.686 | 0.667 | 0.598 | 0.624 | 0.508 |
| Selling & Marketing Expenses
| 0.003 | 0.003 | 0.003 | 0.016 | 0.034 | 0.03 | 0.177 | 0.105 | 0.041 | 0.052 | 0.121 | 0.03 |
| SG&A
| 0.527 | 0.947 | 0.925 | 0.968 | 1.091 | 1.096 | 0.923 | 0.791 | 0.708 | 0.65 | 0.745 | 0.539 |
| Other Expenses
| 0.365 | 0 | 0.107 | 0.086 | -0.033 | 0.046 | 0.002 | 0.092 | 0.046 | 0.03 | 0.002 | 0.008 |
| Operating Expenses
| 0.892 | 0.947 | 1.032 | 1.054 | 1.059 | 1.142 | 0.949 | 0.791 | 0.708 | 0.65 | 0.749 | 0.552 |
| Operating Income
| -0.438 | -0.506 | -0.129 | -0.591 | -0.839 | -0.564 | -0.566 | -0.588 | -0.507 | -0.288 | -0.506 | -0.144 |
| Operating Income Ratio
| -0.623 | -0.583 | -0.099 | -0.602 | -1.167 | -0.436 | -0.761 | -1.226 | -1.094 | -0.243 | -1.097 | -0.247 |
| Total Other Income Expenses Net
| -0.018 | -0.041 | -0.021 | -0.013 | -0.014 | -0 | -0.296 | 0.099 | 0.039 | 0.021 | -0.013 | 0.004 |
| Income Before Tax
| -0.456 | -0.547 | -0.15 | -0.604 | -0.852 | -0.577 | -0.862 | -0.49 | -0.468 | -0.26 | -0.519 | -0.139 |
| Income Before Tax Ratio
| -0.649 | -0.63 | -0.115 | -0.615 | -1.187 | -0.447 | -1.159 | -1.021 | -1.01 | -0.22 | -1.125 | -0.24 |
| Income Tax Expense
| 0 | 0 | 0.011 | 0.008 | 0.008 | 0.002 | -0.219 | -0.001 | 0.001 | -0.006 | 0.001 | 0 |
| Net Income
| -0.456 | -0.547 | -0.161 | -0.611 | -0.86 | -0.58 | -0.862 | -0.49 | -0.468 | -0.26 | -0.519 | -0.139 |
| Net Income Ratio
| -0.649 | -0.63 | -0.124 | -0.623 | -1.197 | -0.448 | -1.159 | -1.021 | -1.01 | -0.22 | -1.125 | -0.24 |
| EPS
| -0.007 | -0.008 | -0.002 | -0.009 | -0.013 | -0.008 | -0.013 | -0.007 | -0.007 | -0.004 | -0.01 | -0.003 |
| EPS Diluted
| -0.007 | -0.008 | -0.002 | -0.009 | -0.013 | -0.008 | -0.013 | -0.007 | -0.007 | -0.004 | -0.01 | -0.003 |
| EBITDA
| -0.342 | -0.411 | -0.032 | -0.496 | -0.744 | -0.526 | -0.54 | -0.586 | -0.501 | -0.259 | -0.505 | -0.144 |
| EBITDA Ratio
| -0.487 | -0.473 | -0.025 | -0.505 | -1.036 | -0.407 | -0.726 | -1.222 | -1.081 | -0.218 | -1.093 | -0.247 |